This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Jun;17(6):e70117.

doi: 10.1111/1753-0407.70117.

Monitoring Sarcopenia With Incretin Receptor Activator Treatment

Zachary T Bloomgarden¹

Affiliations

PMID: 40530788
PMCID: PMC12175196
DOI: 10.1111/1753-0407.70117

Editorial

Monitoring Sarcopenia With Incretin Receptor Activator Treatment

Zachary T Bloomgarden. J Diabetes. 2025 Jun.

. 2025 Jun;17(6):e70117.

doi: 10.1111/1753-0407.70117.

Author

Zachary T Bloomgarden¹

Affiliation

¹ Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

PMID: 40530788
PMCID: PMC12175196
DOI: 10.1111/1753-0407.70117

No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

FIGURE 1
Incorporation of measures of sarcopenia into approaches to the use of incretin receptor agonists.

See this image and copyright information in PMC

Similar articles

Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia.
Alnaser RI, Alassaf FA, Abed MN. Alnaser RI, et al. J Bone Metab. 2024 Nov;31(4):251-263. doi: 10.11005/jbm.24.739. Epub 2024 Nov 4. J Bone Metab. 2024. PMID: 39496297 Free PMC article.
Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?
Dreher L, Kylies D, Danser AHJ, Wenzel UO. Dreher L, et al. Hypertension. 2025 Jul;82(7):1167-1174. doi: 10.1161/HYPERTENSIONAHA.125.25112. Epub 2025 May 23. Hypertension. 2025. PMID: 40406862 Review.
Incretin system and glucagon secretion in patients with chronic pancreatitis.
Ciccarelli G, Di Giuseppe G, Gliozzo G, Soldovieri L, Quero G, Nista EC, Brunetti M, Cinti F, De Lucia SS, Hartmann B, Mari A, Gasbarrini A, Alfieri S, Pontecorvi A, Juul Holst J, Giaccari A, Mezza T. Ciccarelli G, et al. Eur J Clin Invest. 2025 Jun 19:e70093. doi: 10.1111/eci.70093. Online ahead of print. Eur J Clin Invest. 2025. PMID: 40536353
Sarcopenia and Risk of Cognitive Impairment: Cohort Study and Mendelian Randomization Analysis.
Sha T, Zhang Y, Wei J, Li C, Zeng C, Lei G, Wang Y. Sha T, et al. JMIR Aging. 2025 Jun 11;8:e66031. doi: 10.2196/66031. JMIR Aging. 2025. PMID: 40499039 Free PMC article.
A Review of Incretin Therapies Approved and in Late-Stage Development for Overweight and Obesity Management.
Chetty AK, Rafi E, Bellini NJ, Buchholz N, Isaacs D. Chetty AK, et al. Endocr Pract. 2024 Mar;30(3):292-303. doi: 10.1016/j.eprac.2023.12.010. Epub 2023 Dec 18. Endocr Pract. 2024. PMID: 38122931 Review.

See all similar articles

References

1. World Obesity Federation , “World Obesity Atlas 2023,” https://data.worldobesity.org/publications/?cat=19.
1. Badve S. V., Bilal A., Lee M. M. Y., et al., “Effects of GLP‐1 Receptor Agonists on Kidney and Cardiovascular Disease Outcomes: A Meta‐Analysis of Randomised Controlled Trials,” Lancet Diabetes & Endocrinology 13, no. 1 (2025): 15–28. - PubMed
1. Bloomgarden Z., “Sarcopenia,” Journal of Diabetes 16, no. 10 (2024): e70025. - PMC - PubMed
1. Gallagher D., Visser M., De Meersman R. E., et al., “Appendicular Skeletal Muscle Mass: Effects of Age, Gender, and Ethnicity,” Journal of Applied Physiology 83, no. 1 (1997): 229–239. - PubMed
1. Xu M., Gong Y., and Yin X., “Total and Regional Fat‐to‐Muscle Mass Ratio in Relation to All‐Cause and Cause‐Specific Mortality in Men and Women,” Journal of Clinical Endocrinology and Metabolism 110 (2024): e2054–e2063, 10.1210/clinem/dgae595. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources